American Century Companies Inc Ascendis Pharma A/S Transaction History

American Century Companies Inc

$167 Billion
Q3 2024

A detailed history of American Century Companies Inc transactions in Ascendis Pharma A/S stock. As of the latest transaction made, American Century Companies Inc holds 346,746 shares of ASND stock, worth $47.7 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

346,746

Previous 305,974 13.33%

Holding current value

$47.7 Million

Previous $41.7 Million 24.1%

% of portfolio

0.03%

Previous 0.03%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$113.0 - $153.43 $4.61 Million - $6.26 Million	40,772 Added 13.33%	346,746 $51.8 Million
Q2 2024 Aug 07, 2024	SELL	$121.07 - $153.67 $20,218 - $25,662	-167 Reduced 0.05%	305,974 $41.7 Million
Q1 2024 May 14, 2024	SELL	$123.45 - $159.4 $197,026 - $254,402	-1,596 Reduced 0.52%	306,141 $46.3 Million
Q4 2023 Feb 13, 2024	BUY	$86.1 - $127.36 $26.5 Million - $39.2 Million	307,737 New	307,737 $38.8 Million
Q3 2023 Nov 13, 2023	SELL	$86.5 - $103.97 $2.86 Million - $3.44 Million	-33,092 Reduced 9.13%	329,274 $30.8 Million
Q2 2023 Aug 14, 2023	BUY	$69.96 - $97.84 $400,800 - $560,525	5,729 Added 1.61%	362,366 $32.3 Million
Q1 2023 May 11, 2023	BUY	$104.9 - $126.78 $1.36 Million - $1.64 Million	12,943 Added 3.77%	356,637 $38.2 Million
Q4 2022 Feb 13, 2023	BUY	$99.42 - $131.97 $108,765 - $144,375	1,094 Added 0.32%	343,694 $42 Million
Q3 2022 Nov 14, 2022	BUY	$84.03 - $110.23 $177,639 - $233,026	2,114 Added 0.62%	342,600 $35.4 Million
Q2 2022 Aug 12, 2022	SELL	$78.08 - $117.61 $965,068 - $1.45 Million	-12,360 Reduced 3.5%	340,486 $31.7 Million
Q1 2022 May 11, 2022	BUY	$102.18 - $135.75 $3.13 Million - $4.16 Million	30,648 Added 9.51%	352,846 $41.4 Million
Q4 2021 Feb 07, 2022	BUY	$127.1 - $169.66 $5.83 Million - $7.78 Million	45,865 Added 16.6%	322,198 $43.3 Million
Q3 2021 Nov 10, 2021	BUY	$112.67 - $176.92 $1.83 Million - $2.87 Million	16,230 Added 6.24%	276,333 $44 Million
Q2 2021 Aug 05, 2021	BUY	$121.62 - $145.29 $7.38 Million - $8.82 Million	60,720 Added 30.45%	260,103 $34.2 Million
Q1 2021 May 14, 2021	BUY	$124.92 - $173.33 $24.9 Million - $34.6 Million	199,383 New	199,383 $25.7 Million

Others Institutions Holding ASND

# of Institutions

244

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.68B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Ascendis Pharma A/S Transaction History